[Final Program, International Conference on AIDS (4th: 1988: Stockholm, Sweden), Book 2]
Annotations Tools
2533 A SIX MONTH FOLLOW-UP OF PATIENTS WITH AIDS AND ARC: INTERFERON PRODUCTION AND CLINICAL DATA, Kris Huygent, S Sprechera and H Taelmant, * Pasteur Institute of Brabant, 1180 Brussels I Institute for Tropical Medicine, 2000 Antwerp BELGIUM, At the unset of the study, five HIV+ patients with ARC(I-5) and six with AIDS(6-11) were examined for in vitro lymphokine production (using a total blood assay) in response to Newcastle Disease Virus (IFN-a) and Phytohemagglutinin (IFN-Y,IL-2) and for presence of in vivo IFN-a in the serum: Diagnosis IV C-2 IV A IV C-2 IV A IV A IV C-1 IV C-1 IV C-1 IV C-1 IV C-1 IV D Serua IFN + + ++ + + + IFN-a low low normal noreal normal low low low low low low IFN-I low impaired normal normal normal impaired low low normal low normal IL-2 low low normal normal low low low low normal low ND T4/pl T4/T8 92 0,13 176 0,29 454 0,46 632 0,39 87 0,07 2534 A POSTULATED ROLE FOR DECREASING E-CR AND TRIPLE POSITIVE DIRECT COOMBS' TEST IN THE PATHOGENESIS OF HIV INFECTION M Lange, Y Inada, EB Klein, W Ramey, LZ Cooper MH Grieco. St. Luke's-Roosevelt Hospital Center, Columbia University New York, NY USA Objective.As previously reported, we found a strong correlation between the presence of serum acid-labile alpha interferon and low or absent erythrocyte receptor activity for ccmplement 3b(E-CR1) and the progression towards clinical AIDS. We define here the relationship between E-CR1 activity and the development of a direct Coombs' test for IgG(r), IgM(u) andC3 on erythrocyte surfaces in a cohort of 108 hanosexuals. Methods. 108 healthy homosexual volunteers (H/S) were recruited in 1981/82 and followed at 6 monthly intervals. E-CR1 and direct Cocmbs' tests were determined at 6 monthly intervals since 5/83. Results. 60 H/S were seropositive(H+), 42 seronegative(H-), 6 seroconverted(H+)for HIV antibody. Of 54 H+ H/S, 24 had 25% or less of normal CR1 activity and a triple positive direct Concbs'(r,u,C3) on one or more ocasion in the 12-mo interval between 5/83 and 5/84. Of these 19 progressed to AIDS, 4 to ARC and 1 seroconverted. In controls of 34 H- volunteers tested during the same time interval, the above cambination of 25% CR1 and r,u,C3 Cocmbs'was found in only 1 volunteer who developed multiple sclerosis. Conclusion. Our previous report of more than 90% incidence colonization with viruses other than HIV in this cohort was not associated with a difference in incidence between the H+ and H- group. CR1 functions in the inactivation and elimination of pathogenic immune canplexes(IC).We therefore postulate that saturation of this system either due to excess IC production and/or decreased macrophage phagocytosis is reflected in the-cmanbination of decreased CR1 and triple Cocts'reflect a pathogenic mechanism directly involed in the progression to overt AIDS. 6 7 8 9 10 1 23 15 25 179 12 436 0,05 0,05 0,04 0,18 0,50 0,35 Presence of acid-labile IFN-a in the serum correlated to decreased IFN-Y/ IL-2 production, Both parameters reflected poor general health status and could be used as prognostic markers for future evolution of the disease, AZT was administered p,o, at 2 g/day during the first month, and at 1 g/day during the next 5 months to patients 1,3,4,8,9 and 10, No significant changes could be observed in IFN-production capacity or in serum IFN levels, during this six month treatment period, Two of the AIDS patients died during the follow-up period, pt 7 in the third month and pt 8 in the sixth month, AZT treatment was well supported and subjective improvement and weight increases were observed in most patients, Notes: 2535 PROGNOSTIC VALUE OF SERUM INTERFERON ALPHA, HIV ANTIGEN, AND HIV CORE ANTIBODIES IN HIVINFECTED PATIENTS Jochen Abb Institute of Microbiology, Ludwigsburg Hospital, Ludwigsburg, Federal Republic of Germany Objective. To determine interferon (IFN) alpha, HIV antigen (HIV-Ag), and HIV core antibodies (anti-HIV core) in sera from HIV-infected patients and to assess their prognostic value. Methods. Serum IFN alpha was determined by measuring the inhibition of viral cytopathic effect on bovine kidney cells. HIV-Ag and anti-HIV core were determined by enzyme immunoassay (Abbott). Results. Data on the presence of IFN alpha, HIV-Ag, and anti-HIV core in sera from patients with different manifestations of HIV infection are given in the table. Table. IFN alpha, HIV-Ag, and anti-HIV core in sera from HIV-infected patients. CDC class. Serum IFN HIV-Ag Anti-HIV core group Pos./total Pos./total Neg./total I 2/ 5( 40%) 4/ 5(80%) 5/ 5(100%) II 0/82( 0%) 0/82( 0%) 0/82( 0%) III 23/41( 56%) 11/41(27%) 10/41( 24%) IV 29/29(100%) 22/29(76%) 22/29( 76%) Nine patients showed progression to clinical symptoms of AIDS during the study period. The presence of serum IFN alpha heralded the onset of AIDS in 9/9 patients; the presence of HIV-Ag and lack of anti-HIV core was demonstrated in 7/9 patients. Conclusions. The persistent presence of IFN alpha appears to be the most reliable serological marker for disease progression in individuals exposed to HIV. 2536 IMMUNOLOGICAL ABNORMALITIES IN HIV INFECTION R. M&fiez*, A. Bofill**, T. Figuera**, T. Espafiol**. "Intensive Care Department, "" Immunology Unit. Hosp. General "Valle de Hebr6n". Barcelona. Spain. Obiective. HIV infection is not always followed by the development of AIDS. Immunological abnormalities, antigenemic load and recurrent infections would be factors in the progression of the disease. We have studied some immunological parameters: Ta, T4, T,, IL-2 receptor positive cells, IL-2 and r-IFN productions and PHA stimulation, in order to find diferences that could have prognostic value. Methods. 39 patients were studied 22 HIV asymptomatic carriers, 8 LAS, 9 AIDS and a control group of blood banc donors. T lymphocytes and T subsets were measured with an indirect immunofluorescence method with MoAb. IL-2 receptors were investigated in 48 h. PHA-stimulated lymphocytes. This cultures supernatants were stored for IL-2 and T-IFN levels. IL-2 microassay was performed in CTLL-2 microtest. r-IFN was measured by RIA ("forward sandwich" principle). Results. T-IFN production and mainly IL-2 receptors in stimulated lymphocyte had statistically diferences (p ( 0.001) between asymptomatic and symptomatic patients (LAS and AIDS), and IL-2 production and PHA stimulation (p < 0.05) between LAS and AIDS. Conclusion, These immunological parameters have an important prognostic value and could help to select suitable patients to be treated. 109
-
Scan #1
Page #1
-
Scan #2
Page #2
-
Scan #3
Page 1 - Title Page
-
Scan #4
Page 2 - Table of Contents
-
Scan #5
Page 3
-
Scan #6
Page 4
-
Scan #7
Page 5
-
Scan #8
Page 6
-
Scan #9
Page 7
-
Scan #10
Page 8-9
-
Scan #11
Page 10
-
Scan #12
Page 11
-
Scan #13
Page 12
-
Scan #14
Page 13
-
Scan #15
Page 14
-
Scan #16
Page 15
-
Scan #17
Page 16
-
Scan #18
Page 17
-
Scan #19
Page 18-19
-
Scan #20
Page 20
-
Scan #21
Page 21
-
Scan #22
Page 22
-
Scan #23
Page 23
-
Scan #24
Page 24
-
Scan #25
Page 25
-
Scan #26
Page 26
-
Scan #27
Page 27
-
Scan #28
Page 28
-
Scan #29
Page 29
-
Scan #30
Page 30
-
Scan #31
Page 31
-
Scan #32
Page 32
-
Scan #33
Page 33
-
Scan #34
Page 34
-
Scan #35
Page 35
-
Scan #36
Page 36
-
Scan #37
Page 37
-
Scan #38
Page 38
-
Scan #39
Page 39
-
Scan #40
Page 40
-
Scan #41
Page 41
-
Scan #42
Page 42
-
Scan #43
Page 43
-
Scan #44
Page 44
-
Scan #45
Page 45
-
Scan #46
Page 46
-
Scan #47
Page 47
-
Scan #48
Page 48
-
Scan #49
Page 49
-
Scan #50
Page 50
-
Scan #51
Page 51
-
Scan #52
Page 52
-
Scan #53
Page 53
-
Scan #54
Page 54
-
Scan #55
Page 55
-
Scan #56
Page 56
-
Scan #57
Page 57
-
Scan #58
Page 58
-
Scan #59
Page 59
-
Scan #60
Page 60
-
Scan #61
Page 61
-
Scan #62
Page 62
-
Scan #63
Page 63
-
Scan #64
Page 64
-
Scan #65
Page 65
-
Scan #66
Page 66
-
Scan #67
Page 67
-
Scan #68
Page 68
-
Scan #69
Page 69
-
Scan #70
Page 70
-
Scan #71
Page 71
-
Scan #72
Page 72
-
Scan #73
Page 73
-
Scan #74
Page 74
-
Scan #75
Page 75
-
Scan #76
Page 76
-
Scan #77
Page 77
-
Scan #78
Page 78
-
Scan #79
Page 79
-
Scan #80
Page 80
-
Scan #81
Page 81
-
Scan #82
Page 82
-
Scan #83
Page 83
-
Scan #84
Page 84
-
Scan #85
Page 85
-
Scan #86
Page 86
-
Scan #87
Page 87
-
Scan #88
Page 88
-
Scan #89
Page 89
-
Scan #90
Page 90
-
Scan #91
Page 91
-
Scan #92
Page 92
-
Scan #93
Page 93
-
Scan #94
Page 94
-
Scan #95
Page 95
-
Scan #96
Page 96
-
Scan #97
Page 97
-
Scan #98
Page 98
-
Scan #99
Page 99
-
Scan #100
Page 100
-
Scan #101
Page 101
-
Scan #102
Page 102
-
Scan #103
Page 103
-
Scan #104
Page 104
-
Scan #105
Page 105
-
Scan #106
Page 106
-
Scan #107
Page 107
-
Scan #108
Page 108
-
Scan #109
Page 109
-
Scan #110
Page 110
-
Scan #111
Page 111
-
Scan #112
Page 112
-
Scan #113
Page 113
-
Scan #114
Page 114
-
Scan #115
Page 115
-
Scan #116
Page 116
-
Scan #117
Page 117
-
Scan #118
Page 118
-
Scan #119
Page 119
-
Scan #120
Page 120
-
Scan #121
Page 121
-
Scan #122
Page 122
-
Scan #123
Page 123
-
Scan #124
Page 124
-
Scan #125
Page 125
-
Scan #126
Page 126
-
Scan #127
Page 127
-
Scan #128
Page 128
-
Scan #129
Page 129
-
Scan #130
Page 130
-
Scan #131
Page 131
-
Scan #132
Page 132
-
Scan #133
Page 133
-
Scan #134
Page 134
-
Scan #135
Page 135
-
Scan #136
Page 136
-
Scan #137
Page 137
-
Scan #138
Page 138
-
Scan #139
Page 139
-
Scan #140
Page 140
-
Scan #141
Page 141
-
Scan #142
Page 142
-
Scan #143
Page 143
-
Scan #144
Page 144
-
Scan #145
Page 145
-
Scan #146
Page 146
-
Scan #147
Page 147
-
Scan #148
Page 148
-
Scan #149
Page 149
-
Scan #150
Page 150
-
Scan #151
Page 151
-
Scan #152
Page 152
-
Scan #153
Page 153
-
Scan #154
Page 154
-
Scan #155
Page 155
-
Scan #156
Page 156
-
Scan #157
Page 157
-
Scan #158
Page 158
-
Scan #159
Page 159
-
Scan #160
Page 160
-
Scan #161
Page 161
-
Scan #162
Page 162
-
Scan #163
Page 163
-
Scan #164
Page 164
-
Scan #165
Page 165
-
Scan #166
Page 166
-
Scan #167
Page 167
-
Scan #168
Page 168
-
Scan #169
Page 169
-
Scan #170
Page 170
-
Scan #171
Page 171
-
Scan #172
Page 172
-
Scan #173
Page 173
-
Scan #174
Page 174
-
Scan #175
Page 175
-
Scan #176
Page 176
-
Scan #177
Page 177
-
Scan #178
Page 178
-
Scan #179
Page 179
-
Scan #180
Page 180
-
Scan #181
Page 181
-
Scan #182
Page 182
-
Scan #183
Page 183
-
Scan #184
Page 184
-
Scan #185
Page 185
-
Scan #186
Page 186
-
Scan #187
Page 187
-
Scan #188
Page 188
-
Scan #189
Page 189
-
Scan #190
Page 190
-
Scan #191
Page 191
-
Scan #192
Page 192
-
Scan #193
Page 193
-
Scan #194
Page 194
-
Scan #195
Page 195
-
Scan #196
Page 196
-
Scan #197
Page 197
-
Scan #198
Page 198
-
Scan #199
Page 199
-
Scan #200
Page 200
-
Scan #201
Page 201
-
Scan #202
Page 202
-
Scan #203
Page 203
-
Scan #204
Page 204
-
Scan #205
Page 205
-
Scan #206
Page 206
-
Scan #207
Page 207
-
Scan #208
Page 208
-
Scan #209
Page 209
-
Scan #210
Page 210
-
Scan #211
Page 211
-
Scan #212
Page 212
-
Scan #213
Page 213
-
Scan #214
Page 214
-
Scan #215
Page 215
-
Scan #216
Page 216
-
Scan #217
Page 217
-
Scan #218
Page 218
-
Scan #219
Page 219
-
Scan #220
Page 220
-
Scan #221
Page 221
-
Scan #222
Page 222
-
Scan #223
Page 223
-
Scan #224
Page 224
-
Scan #225
Page 225
-
Scan #226
Page 226
-
Scan #227
Page 227
-
Scan #228
Page 228
-
Scan #229
Page 229
-
Scan #230
Page 230
-
Scan #231
Page 231
-
Scan #232
Page 232
-
Scan #233
Page 233
-
Scan #234
Page 234
-
Scan #235
Page 235
-
Scan #236
Page 236
-
Scan #237
Page 237
-
Scan #238
Page 238
-
Scan #239
Page 239
-
Scan #240
Page 240
-
Scan #241
Page 241
-
Scan #242
Page 242
-
Scan #243
Page 243
-
Scan #244
Page 244
-
Scan #245
Page 245
-
Scan #246
Page 246
-
Scan #247
Page 247
-
Scan #248
Page 248
-
Scan #249
Page 249
-
Scan #250
Page 250
-
Scan #251
Page 251
-
Scan #252
Page 252
-
Scan #253
Page 253
-
Scan #254
Page 254
-
Scan #255
Page 255
-
Scan #256
Page 256
-
Scan #257
Page 257
-
Scan #258
Page 258
-
Scan #259
Page 259
-
Scan #260
Page 260
-
Scan #261
Page 261
-
Scan #262
Page 262
-
Scan #263
Page 263
-
Scan #264
Page 264
-
Scan #265
Page 265
-
Scan #266
Page 266
-
Scan #267
Page 267
-
Scan #268
Page 268
-
Scan #269
Page 269
-
Scan #270
Page 270
-
Scan #271
Page 271
-
Scan #272
Page 272
-
Scan #273
Page 273
-
Scan #274
Page 274
-
Scan #275
Page 275
-
Scan #276
Page 276
-
Scan #277
Page 277
-
Scan #278
Page 278
-
Scan #279
Page 279
-
Scan #280
Page 280
-
Scan #281
Page 281
-
Scan #282
Page 282
-
Scan #283
Page 283
-
Scan #284
Page 284
-
Scan #285
Page 285
-
Scan #286
Page 286
-
Scan #287
Page 287
-
Scan #288
Page 288
-
Scan #289
Page 289
-
Scan #290
Page 290
-
Scan #291
Page 291
-
Scan #292
Page 292
-
Scan #293
Page 293
-
Scan #294
Page 294
-
Scan #295
Page 295
-
Scan #296
Page 296
-
Scan #297
Page 297
-
Scan #298
Page 298
-
Scan #299
Page 299
-
Scan #300
Page 300
-
Scan #301
Page 301
-
Scan #302
Page 302
-
Scan #303
Page 303
-
Scan #304
Page 304
-
Scan #305
Page 305
-
Scan #306
Page 306
-
Scan #307
Page 307
-
Scan #308
Page 308
-
Scan #309
Page 309
-
Scan #310
Page 310
-
Scan #311
Page 311
-
Scan #312
Page 312
-
Scan #313
Page 313
-
Scan #314
Page 314
-
Scan #315
Page 315
-
Scan #316
Page 316
-
Scan #317
Page 317
-
Scan #318
Page 318
-
Scan #319
Page 319
-
Scan #320
Page 320
-
Scan #321
Page 321
-
Scan #322
Page 322
-
Scan #323
Page 323
-
Scan #324
Page 324
-
Scan #325
Page 325
-
Scan #326
Page 326
-
Scan #327
Page 327
-
Scan #328
Page 328
-
Scan #329
Page 329
-
Scan #330
Page 330
-
Scan #331
Page 331
-
Scan #332
Page 332
-
Scan #333
Page 333
-
Scan #334
Page 334
-
Scan #335
Page 335
-
Scan #336
Page 336
-
Scan #337
Page 337
-
Scan #338
Page 338
-
Scan #339
Page 339
-
Scan #340
Page 340
-
Scan #341
Page 341
-
Scan #342
Page 342
-
Scan #343
Page 343
-
Scan #344
Page 344
-
Scan #345
Page 345
-
Scan #346
Page 346
-
Scan #347
Page 347
-
Scan #348
Page 348
-
Scan #349
Page 349
-
Scan #350
Page 350
-
Scan #351
Page 351
-
Scan #352
Page 352
-
Scan #353
Page 353
-
Scan #354
Page 354
-
Scan #355
Page 355
-
Scan #356
Page 356
-
Scan #357
Page 357
-
Scan #358
Page 358
-
Scan #359
Page 359
-
Scan #360
Page 360
-
Scan #361
Page 361
-
Scan #362
Page 362
-
Scan #363
Page 363
-
Scan #364
Page 364
-
Scan #365
Page 365
-
Scan #366
Page 366
-
Scan #367
Page 367
-
Scan #368
Page 368
-
Scan #369
Page 369
-
Scan #370
Page 370
-
Scan #371
Page 371
-
Scan #372
Page 372
-
Scan #373
Page 373
-
Scan #374
Page 374
-
Scan #375
Page 375
-
Scan #376
Page 376
-
Scan #377
Page 377
-
Scan #378
Page 378
-
Scan #379
Page 379
-
Scan #380
Page 380
-
Scan #381
Page 381
-
Scan #382
Page 382
-
Scan #383
Page 383
-
Scan #384
Page 384
-
Scan #385
Page 385
-
Scan #386
Page 386
-
Scan #387
Page 387
-
Scan #388
Page 388
-
Scan #389
Page 389
-
Scan #390
Page 390
-
Scan #391
Page 391
-
Scan #392
Page 392
-
Scan #393
Page 393
-
Scan #394
Page 394
-
Scan #395
Page 395
-
Scan #396
Page 396
-
Scan #397
Page 397
-
Scan #398
Page 398
-
Scan #399
Page 399
-
Scan #400
Page 400
-
Scan #401
Page 401
-
Scan #402
Page 402
-
Scan #403
Page 403
-
Scan #404
Page 404
-
Scan #405
Page 405
-
Scan #406
Page 406
-
Scan #407
Page 407
-
Scan #408
Page 408
-
Scan #409
Page 409
-
Scan #410
Page 410
-
Scan #411
Page 411
-
Scan #412
Page 412
-
Scan #413
Page 413
-
Scan #414
Page 414
-
Scan #415
Page 415
-
Scan #416
Page 416
-
Scan #417
Page 417
-
Scan #418
Page 418
-
Scan #419
Page 419
-
Scan #420
Page 420
-
Scan #421
Page 421
-
Scan #422
Page 422
-
Scan #423
Page 423
-
Scan #424
Page 424
-
Scan #425
Page 425
-
Scan #426
Page 426
-
Scan #427
Page 427
-
Scan #428
Page 428
-
Scan #429
Page 429
-
Scan #430
Page 430
-
Scan #431
Page 431
-
Scan #432
Page 432
-
Scan #433
Page 433
-
Scan #434
Page 434
-
Scan #435
Page 435
-
Scan #436
Page 436
-
Scan #437
Page 437
-
Scan #438
Page #438
-
Scan #439
Page #439
-
Scan #440
Page #440
-
Scan #441
Page #441
-
Scan #442
Page #442
Actions
About this Item
- Title
- [Final Program, International Conference on AIDS (4th: 1988: Stockholm, Sweden), Book 2]
- Author
- International AIDS Society
- Canvas
- Page 109
- Publication
- 1988
- Subject terms
- programs
- Series/Folder Title
- Chronological Files > 1985 - 1989 > Events > International Conference on AIDS (4th: 1988: Stockholm, Sweden)
- Item type:
- programs
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0006.002
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0006.002/109
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0006.002
Cite this Item
- Full citation
-
"[Final Program, International Conference on AIDS (4th: 1988: Stockholm, Sweden), Book 2]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0006.002. University of Michigan Library Digital Collections. Accessed June 25, 2025.